Sand Grove Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Sand Grove Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-992,068	Closed	-$23.7M	–	41
2021 Q1	$23.7M	Buy	+992,068	New	+$18.4M	2.31%	12

Sand Grove Capital Management's GNMK Position: Q2 2021 in Review

Sand Grove Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 992,068 shares — an estimated $23.7M sold.

Sand Grove Capital Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $23.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Sand Grove Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Sand Grove Capital Management sold 992,068 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $23.7M.
Sand Grove Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Sand Grove Capital Management's GenMark Diagnostics, Inc position peaked at $23.7M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Sand Grove Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.